FIGURE
Figure 1— supplement 2.
- ID
- ZDB-FIG-230707-64
- Publication
- Chen et al., 2023 - Defining function of wild-type and three patient specific TP53 mutations in a zebrafish model of embryonal rhabdomyosarcoma
- Other Figures
-
- Figure 1
- Figure 1— supplement 1.
- Figure 1— supplement 2.
- Figure 2.
- Figure 3
- Figure 3—figure supplement 1.
- Figure 3—figure supplement 2.
- Figure 3—figure supplement 3.
- Figure 3—figure supplement 4.
- Figure 4
- Figure 4—figure supplement 1.
- Figure 4—figure supplement 2.
- Figure 4—figure supplement 3.
- Figure 5
- Figure 5—figure supplement 1.
- Figure 5—figure supplement 2.
- Figure 5—figure supplement 3.
- Figure 5—figure supplement 4.
- Figure 6
- Figure 6—figure supplement 1.
- Figure 6—figure supplement 2.
- Figure 6—figure supplement 3.
- Figure 6—figure supplement 4.
- Figure 7
- Figure 7—figure supplement 1.
- All Figure Page
- Back to All Figure Page
Figure 1— supplement 2.
tp53 suppresses embryonal rhabdomyosarcoma (ERMS) tumor initiation. (A) mRNA expression of kRASG12D and dusp4 in compared to 18s expression level. (B) Representative H&E and immunohistochemistry (anti-DsRed) staining in embryonal rhabdomyosarcoma (ERMS) tumor fish. Arrows denote location of tumors. Zebrafish shown are 35 days old. Scale bar = 100 µm. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Elife